These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 32923313)
1. Electrostatic reaction for the detection of circulating tumor cells as a potential diagnostic biomarker for metastasis in solid tumor. Li Z; Liu X; Zhang W; Zhuang X Nanotheranostics; 2020; 4(4):233-241. PubMed ID: 32923313 [TBL] [Abstract][Full Text] [Related]
2. Effective capture of circulating tumor cells from an S180-bearing mouse model using electrically charged magnetic nanoparticles. Li Z; Ruan J; Zhuang X J Nanobiotechnology; 2019 May; 17(1):59. PubMed ID: 31054582 [TBL] [Abstract][Full Text] [Related]
3. Multifunctional luminescent immuno-magnetic nanoparticles: toward fast, efficient, cell-friendly capture and recovery of circulating tumor cells. Zhou X; Luo B; Kang K; Ma S; Sun X; Lan F; Yi Q; Wu Y J Mater Chem B; 2019 Jan; 7(3):393-400. PubMed ID: 32254726 [TBL] [Abstract][Full Text] [Related]
4. Greatly isolated heterogeneous circulating tumor cells using hybrid engineered cell membrane-camouflaged magnetic nanoparticles. Jiang X; Zhang X; Guo C; Liu Z; Guo X; Tian Z; Wang Z; Yang J; Huang X; Ou L J Nanobiotechnology; 2024 May; 22(1):231. PubMed ID: 38720360 [TBL] [Abstract][Full Text] [Related]
5. High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (CTCs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles. Wang Z; Sun N; Liu H; Chen C; Ding P; Yue X; Zou H; Xing C; Pei R ACS Appl Mater Interfaces; 2019 Oct; 11(43):39586-39593. PubMed ID: 31577122 [TBL] [Abstract][Full Text] [Related]
6. Rapid Label-Free Isolation of Circulating Tumor Cells from Patients' Peripheral Blood Using Electrically Charged Fe Wu S; Gu L; Qin J; Zhang L; Sun F; Liu Z; Wang Y; Shi D ACS Appl Mater Interfaces; 2020 Jan; 12(4):4193-4203. PubMed ID: 31935069 [TBL] [Abstract][Full Text] [Related]
7. Electrochemical Detection of Circulating Tumor Cells Based on DNA Generated Electrochemical Current and Rolling Circle Amplification. Shen C; Liu S; Li X; Yang M Anal Chem; 2019 Sep; 91(18):11614-11619. PubMed ID: 31452368 [TBL] [Abstract][Full Text] [Related]
8. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system. Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409 [TBL] [Abstract][Full Text] [Related]
9. Clinical and biological significance of circulating tumor cells in cancer. Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533 [TBL] [Abstract][Full Text] [Related]
10. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508 [TBL] [Abstract][Full Text] [Related]
11. The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic prostate cancer. Dong L; Zhang Z; Smith K; Kuczler MD; Reyes D; Amend SR; Cho YK; Xue W; Pienta KJ BJU Int; 2020 Jul; 126(1):191-201. PubMed ID: 32115854 [TBL] [Abstract][Full Text] [Related]
12. Rapid and efficient isolation and detection of circulating tumor cells based on ZnS:Mn Cui H; Li R; Du J; Meng QF; Wang Y; Wang ZX; Chen FF; Dong WF; Cao J; Yang LL; Guo SS Talanta; 2019 Sep; 202():230-236. PubMed ID: 31171175 [TBL] [Abstract][Full Text] [Related]
13. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307 [TBL] [Abstract][Full Text] [Related]
14. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer. Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes. Wang C; Ye M; Cheng L; Li R; Zhu W; Shi Z; Fan C; He J; Liu J; Liu Z Biomaterials; 2015 Jun; 54():55-62. PubMed ID: 25907039 [TBL] [Abstract][Full Text] [Related]
16. Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots. Kuo CW; Chueh DY; Chen P J Nanobiotechnology; 2019 Feb; 17(1):26. PubMed ID: 30728024 [TBL] [Abstract][Full Text] [Related]
17. FlowCell-enriched circulating tumor cells as a predictor of lung cancer metastasis. Lu Y; Zheng Y; Wang Y; Gu D; Zhang J; Liu F; Chen K; Guo L Hum Cell; 2021 May; 34(3):945-951. PubMed ID: 33580470 [TBL] [Abstract][Full Text] [Related]
18. Electrochemical assay for analysis of circulation tumor cells based on isolation of the cell with magnetic nanoparticles and reaction of DNA with molybdate. Hou Y; Chen J; Xie B; Li T; Yang M Mikrochim Acta; 2020 Jul; 187(7):420. PubMed ID: 32617688 [TBL] [Abstract][Full Text] [Related]
19. Capture-free deactivation of CTCs in the bloodstream; a metastasis suppression method by electrostatic stimulation of the peripheral blood. Ghaderinia M; Khayamian MA; Abadijoo H; Shalileh S; Faramarzpour M; Zandi A; Simaee H; Abbasvandi F; Esmailinejad MR; Rafizadeh-Tafti S; Jahangiri M; Kordehlachin Y; Ghaffari H; Ansari E; Dabbagh N; Akbari ME; Hoseinpour P; Abdolahad M Biosens Bioelectron; 2021 Jul; 183():113194. PubMed ID: 33813209 [TBL] [Abstract][Full Text] [Related]
20. High Specificity in Circulating Tumor Cell Identification Is Required for Accurate Evaluation of Programmed Death-Ligand 1. Schehr JL; Schultz ZD; Warrick JW; Guckenberger DJ; Pezzi HM; Sperger JM; Heninger E; Saeed A; Leal T; Mattox K; Traynor AM; Campbell TC; Berry SM; Beebe DJ; Lang JM PLoS One; 2016; 11(7):e0159397. PubMed ID: 27459545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]